Volatile anaesthetics reduce neutrophil inflammatory response by interfering with CXC receptor-2 signalling by Müller-Edenborn, B. et al.
TRANSLATIONAL RESEARCH
Volatile anaesthetics reduce neutrophil inflammatory
response by interfering with CXC receptor-2 signalling
B. Mu¨ller-Edenborn1,2, R. Frick1,2, T. Piegeler1,2,3, M. Schla¨pfer1,2, B. Roth-Z’graggen1,2, A. Schlicker1
and B. Beck-Schimmer1,2*
1 Institute of Anaesthesiology, University Hospital Zurich, Zu¨rich, Switzerland
2 Institute of Physiology, Zurich Center of Integrative Human Physiology, University of Zurich, Zu¨rich, Switzerland
3 Department of Anesthesiology, University of Illinois Hospital & Health Sciences Center, Chicago, IL, USA
* Corresponding author. E-mail: beatrice.beckschimmer@uzh.ch
Editor’s key points
† Accumulation of
neutrophils contributes to
ischaemia-reperfusion
injury.
† The role of CXC signalling
in the mechanism of
sevoflurane- and
desflurane-mediated
protection was studied in
human neutrophils.
† Sevoflurane and
desflurane interfered with
CXC receptor-2 signalling.
Background. Growing evidence suggests a protective effect of volatile anaesthetics in
ischaemia-reperfusion (I/R)-injury, and the accumulation of neutrophils is a crucial event.
Pro-inflammatory cytokines carrying the C-X-C-motif including interleukin-8 (IL-8) and CXC-
ligand 1 (CXCL1) activate CXC receptor-1 (CXCR1; stimulated by IL-8), CXC receptor-2
(CXCR2; stimulated by IL-8 and CXCL1), or both to induce CD11b-dependent neutrophil
transmigration. Inhibition of CXCR1, CXCR2, or both reduces I/R-injury by preventing
neutrophil accumulation. We hypothesized that interference with CXCR1/CXCR2 signalling
contributes to the well-established beneficial effect of volatile anaesthetics in I/R-injury.
Methods. Isolated human neutrophils were stimulated with IL-8 or CXCL1 and exposed to
volatile anaesthetics (sevoflurane/desflurane). Neutrophil migration was assessed using an
adapted Boyden chamber. Expression of CD11b, CXCR1, and CXCR2 was measured by flow
cytometry. Blocking antibodies against CXCR1/CXCR2/CD11b and phorbol myristate acetate
were used to investigate specific pathways.
Results. Volatile anaesthetics reduced CD11b-dependent neutrophil transmigration induced
by IL-8 by .30% and CD11b expression by 18 and 27% with sevoflurane/desflurane,
respectively. This effect was independent of CXCR1/CXCR2 expression and CXCR1/CXCR2
endocytosis. Inhibition of CXCR1 signalling did not affect downregulation of CD11b with
volatile anaesthetics. Blocking of CXCR2-signalling neutralized effects by volatile
anaesthetics on CD11b expression. Specific stimulation of CXCR2 with CXCL1 was sufficient
to induce upregulation of CD11b, which was impaired with volatile anaesthetics. No effect
of volatile anaesthetics was observed with direct stimulation of protein kinase C located
downstream of CXCR1/CXCR2.
Conclusion. Volatile anaesthetics attenuate neutrophil inflammatory responses elicited by
CXC cytokines through interference with CXCR2 signalling. This might contribute to the
beneficial effect of volatile anaesthetics in I/R-injury.
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receptors, chemoreceptors
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Ischaemia-reperfusion injury (I/R-injury) during anaesthesia
occurs as an unforeseen event, for example, transient myocar-
dial ischaemia or as a planned step in surgery such as the
Pringle manoeuvre during liver resection. Volatile anaesthetics
protect different organs from I/R-injury such as liver, lung, and
heart.1 – 3 However, the mechanism of this protective effect
remains unclear.
The restoration of blood flow after ischaemia activates
innate and adaptive immune responses leading to an
accumulation of neutrophils in the reperfused organ and sub-
sequent tissue damage.4 Consequently, inhibition of neutrophil
invasion during reperfusion was demonstrated to reduce the
extent of tissue damage.5 – 7
The accumulation of neutrophils in I/R-injury is the result of
a three-step process: first, circulating neutrophils establish a
low-affinity adhesive interaction with the endothelium called
rolling.8 This rolling is mediated by L-selectin (CD62L), which
belongs to the family of glycoproteins on the neutrophil
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surfacethatbinds endothelial carbohydrate determinants. In a
second step, the neutrophil adheres firmly to the endothelium
through adhesion between integrins on the neutrophil surface
and endothelial intercellular adhesion molecules. The most
prominent integrin during this process is CD11b, which binds
to endothelial intercellular adhesion molecule-1. The third
and final step, which involves various adhesive glycoproteins
including CD62L and CD11b, is transmigration of the neutrophil
through the endothelium.
The family of CXC cytokines is defined by two N-terminal
cystines separated by one amino acid (hence C-X-C). A subgroup
of these CXC cytokines carries a Glu-Leu-Arg tripeptide (ELR)
motif at the NH2-end and is termed ELR+ CXC cytokines.
This subgroup includes interleukin-8 (IL-8) and promotes
the recruitment of neutrophils into inflamed tissues.9 ELR+cyto-
kines bind to two G protein-coupled receptors on the neutrophil
surface, CXC receptor-1 (CXCR1) and CXC receptor-2 (CXCR2).10
11 Signalling through these receptors is important during I/
R-injury and pharmacological inhibition was demonstrated to
reduce neutrophil infiltration and subsequent tissue damage.12
We hypothesized that the beneficial effects of volatile anaes-
thetics during I/R-injury are due to direct or indirect effects on
CXCR1 and CXCR2 signalling that might alter the process of neu-
trophil accumulation. We chose IL-8 as a representative ELR+
cytokine as it binds to both CXCR1 and CXCR2 with high affinity
and is released by leucocytes and stromal cells such as fibro-
blasts in high concentrations during reperfusion.13–16
Methods
The study protocol was approved by the ethics committee for
studies on humans of the University Hospital Zurich (KEK-ZH
2012-0274) and written informed consent was obtained.
Twelve healthy volunteers (7 males/5 females, aged 19–52
yrs) were recruited from the Institute of Physiology in Zurich
and blood samples (5 ml) were obtained from an antecubital
vein into citrate tubes. Exclusion criteria were acute disease
in the last 14 days or chronic disease with or without medical
treatment of any type. Oral contraceptives were accepted for
female donors. Red blood cells were lysed and neutrophils
were isolated using Ficoll-Histopaque 1077 (Sigma-Aldrich,
Buchs, Switzerland) as described previously.17 The isolated neu-
trophils were resuspended at a concentration of 2×106 ml21 in
Ham’s F-12 medium supplemented with 10% heat-inactivated
fetal bovine serum, 5% penicillin/streptomycin (10 000 U litre21),
and 5% 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(all from Invitrogen/Life Technologies, Zug, Switzerland). All
steps were performed at 48C to prevent neutrophil activation.
Fifty microlitres of neutrophil cell suspension (105 neutro-
phils) were placed into sterile 96-well plates and exposed to
10 nM IL-8 (recombinant human IL-8, BD Pharmingen,
Allschwil, Switzerland) or 200 ng ml21 CXC-ligand 1 (CXCL1) (re-
combinant human CXCL1, R&D systems, Wiesbaden, Germany).
Phorbol myristate acetate at 10 nM (Sigma-Aldrich) was used to
activate protein kinase C in the corresponding experiments.
These concentrations are commonly used and known to
induce profound neutrophil activation and migration. To study
the effect of I/R in our setting, human lung microvascu-
lar endothelial cells were exposed to 12 h of hypoxia (0.2% O2),
followed by 12 h of reoxygenation at 21% O2. Neutrophils were
then stimulated with the harvested supernatants at 1:1 dilution.
In some experiments, neutrophils were incubated for 15 min
before stimulation with 10 mg ml21 of anti-human CXCR1 and
anti-human CXCR2 (Abcam, Cambridge, UK) or against the acti-
vation epitope of CD11b (anti-human CBRM1/5, Biolegend,
Lucerne, Switzerland). Plates were then put in humified airtight
chambers (Oxoid anaerobic jar; Oxoid AG, Basel, Switzerland).
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Fig 1 Viability of neutrophils exposed to IL-8 with and without sevoflurane or desflurane. Viable neutrophils are negative for annexin and
7-aminoactinomycin (7AAD, Annexin2/7AAD2, blue). Apoptotic neutrophils are positive for annexin and negative for 7AAD (Annexin+/7AAD2,
green). Necrotic cells are positive for annexin and 7AAD (Annexin+/7AAD+, pink). Median, inter-quartile and full range shown (n¼6).
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Chambers were flushed with air/5% CO2 containing 2.2 vol%
sevoflurane (Sevoranew; Abbott AG, Baar, Switzerland, corre-
sponding vaporizer: Sevotec5w; Abbott AG) or 6% vol% desflur-
ane (Forenew, Baxter, Switzerland; corresponding vaporizer:
Tec6, Carbamed, Switzerland). Control cells were exposed to
air/5% CO2 only. Neutrophils from each donor were investi-
gated under all the three conditions. Concentrations of volatile
anaesthetics were measured with the Ohmeda 5330 Agent
Monitor (Abbott AG). After reaching the described concentra-
tions, the chambers were sealed and kept in an incubator at
378C (Bioblock, Ittingen, Switzerland). Volatile anaesthetic con-
centrations were checked again at the end of the incubation
period to ensure that there was no loss of anaesthetic from in-
sufficient sealing or evaporation.17
A 96-well migration plate with 3-mm pores (Millipore-Merck,
Zug, Switzerland) was used to investigate neutrophil migration.
Fifty microlitres of neutrophil suspension (105 cells) was added
to the uppercompartment of the plate. Medium supplemented
with 10 nM IL-8 was added to the lower compartment. Plates
were exposed to volatile anaesthetics as described above im-
mediately after assembly of the plate and neutrophils were
allowed to migrate for 1 h. Migrated neutrophils were quanti-
fied using an automated optical cell counter (TC-10, Biorad,
Cressier, Switzerland).
Surface expression of CXCR1, CXCR2, CD11b, and CD11b
activation epitope was quantified using flow cytometry. Neu-
trophils were kept on ice and fixed with 2% paraformaldehyde
to prevent changes in receptorexpression during staining. Cells
were stained with specific antibodies for 30 min at 48C, washed
twice, and measured on a FACS Canto II (BD Pharmingen). Flow
cytometry raw data were analysed using the FlowJo-Software
for Macintosh (version 8.8.6, Tree Star Inc., Ashland, OR, USA).
The following mouse anti-human antibodies were used (all
antibodies from BD Pharmingen): APC-Cy7-conjugated CD11b
(final staining concentration 2 mg ml21), APC-conjugated CXCR1
(1.25 mg ml21), and FITC-conjugated CXCR2 (0.25 mg ml21).
FITC-conjugated CBRM1/5 (0.2 mg ml21) was obtained from
Biolegend. Appropriate isotype-control antibodies were used
to quantify nonspecific binding.
Neutrophil viability was quantified by staining the cells with
annexin-V and 7-aminoactinomycin (PE Annexin V Apoptosis
Detection Kit I, BD Pharmingen). IL-8 concentrations in super-
natants were quantified using an enzyme-linked immunosorb-
ent assay according to the manufacturer’s protocol (R&D
systems). This kit has a sensitivity range from 31.2 to 2000 pg
ml21 and all samples were diluted to achieve a concentration
in the linear range.
Distribution of the data was assessed using the Kolmo-
gorov–Smirnov test. Normally distributed data were analysed
using a one-way ANOVA with Bonferroni post hoc test. Non-
parametric data were analysed using Kruskal–Wallis and
Dunn’s multiple comparison tests. All experiments were per-
formed with blood from three or more different donors with
conditions repeated in duplicates. A P-value of,0.05 was con-
sidered statistically significant. Statistical analyses and graph
creation were executed with Graphpad Prism 6 for Mac (Graph-
pad Software, La Jolla, CA, USA).
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Fig 2 (A) Neutrophil transmigration in response to IL-8 in the
presence of sevoflurane or desflurane for 1 h. #P,0.0001 vs
control; *P,0.05 vs IL-8 stimulated neutrophils exposed to
air/5% CO2 during transmigration. n¼9. (B) Neutrophil CD11b
expression after 1 h exposure to IL-8 with and without sevoflur-
ane or desflurane. Mean fluorescence of CD11b relative to
control neutrophils not exposed to IL-8 shown. #P,0.0001
vs control neutrophils without IL-8; *P,0.05 vs IL-8 treated
neutrophils without anaesthetic. (n¼12). (C) Neutrophil
activation-epitope of CD11b-specific CBRM1/5 expression.
Mean fluorescence of the antibody clone relative to control
neutrophils not exposed to IL-8 shown. #P,0.001 vs control
neutrophils without IL-8; *P,0.05 vs IL-8 treated neutrophils
without anaesthetic. Median, inter-quartile, and full range
shown (n¼6).
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Results
Our isolation procedure yielded neutrophils with a purity of
.94% and a viability of .99% (data not shown). Exposure to
volatile anaesthetics did not reduce neutrophil viability (Fig. 1).
Exposure to IL-8 induced transmigration of 43% of neutro-
phils within 1 h; exposure to sevoflurane or desflurane
reduced migration by 36 and 32% (Fig. 2A; P¼0.012 for sevo-
flurane, P¼0.032 for desflurane). Neutrophil transmigration
in this setting was dependent upon CD11b and abrogated by
CD11b-blocking antibodies (Supplementary Fig. S1). Accord-
ingly, upregulation of CD11b after stimulation with IL-8 was
attenuated by both sevoflurane and desflurane (Fig. 2B;
P¼0.013 for sevoflurane, P¼0.001 for desflurane). Staining for
the activation-epitope of CD11b revealed a similar pattern with
lower levels ofactivated CD11b inneutrophils exposedtosevoflur-
ane and desflurane (Fig. 2C; P¼0.002 for sevoflurane, P¼0.02 for
desflurane). Reduction of CD11b expression with volatile anaes-
thetics was also observed when neutrophils were stimulated
with supernatants derived from hypoxia/reoxygenation-exposed
endothelial cells (Supplementary Fig. S2).
Stimulation of neutrophils with IL-8 resulted in marked
endocytosis and therefore reduction of surface expression of
CXCR1 by 47% and CXCR2 by 81% (Fig. 3A; P,0.0001). Neither
sevoflurane nor desflurane affected this process. Also, baseline
CXC receptorexpression in resting neutrophils was not affected
by volatile anaesthetics (data not shown). The extent of endo-
cytosis of the ligand–receptor complexes formed by IL-8 and
CXCR1 or CXCR2 resulted in consumption and hence decrease
of free IL-8 in the medium during incubation (Fig. 3B,
P¼0.008). Again, this was not influenced by sevoflurane or
desflurane (Fig. 3B).
Direct stimulation of protein kinase Cwith phorbol myristate
acetate resulted in upregulation of CD11b. No effect of sevo-
flurane and desflurane was observed in this setting (data not
shown).
Blocking antibodies against CXCR1 and CXCR2 inhibited the
upregulation of CD11b in response to IL-8 (Fig. 4A;P,0.001 and
P¼0.01, respectively). However, blocking of CXCR2 before
stimulation neutralized the effect of volatile anaesthetics,
while blocking of CXCR1 resulted in preserved attenuation of
CD11b with sevoflurane and desflurane (Fig. 4B; P,0.05 for
both sevoflurane and desflurane). In addition, stimulation
with CXCL1, to activate CXCR2, reproduced the effect of volatile
anaesthetics (Fig. 4C; P,0.01 for sevoflurane, P,0.001 for
desflurane).
Conclusions
Our study demonstrates that volatile anaesthetics interfere
with neutrophil inflammatory pathways, leading to decreased
neutrophil migration and reduced expression of b2-integrin
CD11b. We locate the site of action of volatile anaesthetics to
be downstream of CXCR2, a target receptor of ELR+ CXC cyto-
kines that are involved in I/R-injury.
We focused the current study on the specific impact of vola-
tile anaesthetics on neutrophil signalling through CXCR1 and
CXCR2. The importance of the ELR+ family of cytokines that
signals through these receptors is well established and their in-
hibition emerges as a new therapeutic option in I/R-injury.9
IL-8 is a suitable cytokine to represent the ELR+ family
because of its high affinity to both of the ELR+ target receptors,
CXCR1 and CXCR2.18 In addition, high levels of IL-8 are released
during I/R-injury, and neutralization of IL-8 was found to
attenuate tissue damage during I/R-injury.16
The accumulation of neutrophils in the reperfused organ
after ischaemia is a multi-step process eventually leading to
local tissue damage.4 Inhibition of this event through various
means such as depletion of neutrophils or antibodies against
neutrophil adhesion molecules decreases tissue injury.7 19
The abilityof neutrophils to transmigrate through the endothe-
lium is pivotal to their accumulation in the reperfused organ.
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Fig 3 (A) CXCR1 (left panel) and CXCR2 (right panel) expression in neutrophils exposed to IL-8 for 1 h with and without sevoflurane or desflurane.
Mean fluorescence relative to control neutrophils without IL-8 shown. #P,0.001 vs control neutrophils without IL-8 (n¼6). (B) IL-8 concentrations
in medium from neutrophils polymorphonuclear leucocyte (PMN) cultured with IL-8 for 1 h with and without sevoflurane or desflurane. Dashed line
shows measured IL-8 concentration in the absence of neutrophils (expected concentration 80 ng ml21). No effect of sevoflurane or desflurane in
IL-8 treated neutrophils. Median, inter-quartile, and full range shown (n¼8).
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We found that sevoflurane and desflurane reduced IL-8
induced transmigration of neutrophils.
The process of transmigration is mediated by several neu-
trophil and endothelial adhesive proteins. However, inhibition
of the neutrophil–endothelial interaction between CD11b on
the neutrophil surface and endothelial intercellular adhesion
molecule-1 proved to be most important.20 CD11b is critical
to establish tight adherence of neutrophils to the endothelium,
and inhibition of CD11b using antibodies blocks neutrophil
recruitment and reduces tissue damage both in vitro and
in vivo.21 22 In our setting, neutrophil transmigration was
dependent on CD11b expression and both sevoflurane and
desflurane attenuated the upregulation of CD11b in response
to IL-8. These findings concur with previous reports demon-
strating the inhibition of neutrophil–endothelial interactions
with isoflurane and sevoflurane.23 24
To elucidate the site of action of volatile anaesthetics, expres-
sion of the ELR+ receptors CXCR1 and CXCR2 which are activated
by IL-8 was determined. These receptors undergo endocytosis
upon ligand binding followed by a recycling step back to the
membrane, which presumably serves to reduce neutrophil ac-
tivity in response to high chemokine concentrations at inflam-
matory sites.25 We found that IL-8 decreased the expression
of CXCR1 and CXCR2. Exposure to volatile anaesthetics did not
influence this effect, nor did it lead to a more pronounced down-
regulation in resting neutrophils. We further investigated the
effect of endocytosis of the CXCR1 and CXCR2 ligand–receptor-
complex on free IL-8 levels. The marked decrease in membrane
CXCR1 and CXCR2, and hence high endocytosis of receptor-
bound IL-8, resulted in diminished levels of IL-8 in the
medium and volatile anaesthetics did not affect this. These
observations suggest that volatile anaesthetics do not induce
changes in CXCR1 or CXCR2 surface expression and endocytosis,
which might have altered neutrophil activity.
Ligand binding to the G protein-coupled receptors CXCR1 and
CXCR2 leads to dissemination of the G protein into the
GTP-bound Gai and the Gbg subunit. Gai then increases the ac-
tivity of phosphatidyl-inositide-3 kinase while Gbg activates
phospholipase C. This leads to an increase of diacylglycerol
that activates protein kinase C, which in turn induces CD11b ex-
pression.26 We found that phorbol myristate acetate, an ana-
logue of diacylglycerol that directly activates protein kinase C
without involvement of surface receptors, upregulates CD11b.
However, no effect of volatile anaesthetics was observed in
this setting. This suggests that volatile anaesthetics alter the
neutrophil ELR+ pathway at a site upstream of protein kinase C.
We next investigated whether the effects of volatile anaes-
thetics were attributable to downstream pathways specific to
CXCR1 or CXCR2. Indeed, blocking of CXCR2 abrogated the
impact of both sevoflurane and desflurane on CD11b expres-
sion. However, blocking of CXCR1 preserved the effects of vola-
tile anaesthetics, although at a lower level of CD11b expression.
We then used CXCL1, a cytokine of the same family as IL-8, but
which binds only to CXCR2. In line with the above findings, we
found that stimulation with CXCL1 reproduced neutrophil in-
hibition by volatile anaesthetics. Sevoflurane and desflurane
–
–
–
+
–
–
+
+
–
+
–
+
0
IL-8 10 nM
Anti-CXCR1 Ab
Anti-CXCR2 Ab
50
CD
11
b 
ex
pr
es
sio
n 
(%
)
re
la
tiv
e
 to
 c
on
tro
l
100
150
200
250A #
*
*
Air
–
–
–
+
–
–
+
+
–
+
–
+
0
IL-8 10 nM
Anti-CXCR1 Ab
Anti-CXCR2 Ab
50
CD
11
b 
ex
pr
es
sio
n 
(%
)
re
la
tiv
e
 to
 c
on
tro
l
100
150
200
250B #
#
#
* *
Air
Sevoflurane
Desflurane
– + + +
0
CXCL1 200 ng ml–1
CD
11
b 
ex
pr
es
sio
n 
(%
)
re
la
tiv
e
 
to
 c
on
tro
l
100
200
300
400C #
* *
Air
Sevoflurane
Desflurane
Fig 4 (A) Effect of anti-CXCR1- or anti-CXCR2-antibodies on CD11b
expression in neutrophils with and without IL-8. Mean fluorescence
of CD11b relative to control neutrophils without IL-8 shown.
#P,0.0001 vs control, *P,0.05 vs IL-8 alone (n¼8). (B) Effect of
anti-CXCR1- or anti-CXCR2-antibodies on CD11b expression in neu-
trophils with and without exposure to sevoflurane or of desflurane.
Mean fluorescence of CD11b relative to control neutrophils without
IL-8 shown. #P,0.0001 vs untreated control, *P,0.05 vs IL-8
without anaesthetics (n¼6). (C) Effect of CXCL1 on CD11b expres-
sion on neutrophils exposed to sevoflurane or desflurane. Mean
fluorescence of CD11b relative to neutrophils without CXCL1
shown. #P,0.05 vs neutrophils without CXCL1, *P,0.01 vs
without anaesthetic. Median, inter-quartile, and full range shown
(n¼6).
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therefore seem to affect IL-8-induced neutrophil activation
downstream of CXCR2. A particular role of CXCR2 during
I/R-injury was also reported by Tarzami and colleagues who
investigated theoutcome of experimental myocardial infarction
in CXCR22/2(knockout) mice: not only were infarct sizes smaller,
suggesting decreased tissue damage but also the number of
infiltrating neutrophils was reduced in the infarcted area.27 In
line with our finding, this also suggests that CXCR2 signalling is
important for leucocyte recruitment in I/R-injury.
Our experimental setup uses an in vitro system of isolated
neutrophils and as such is limited as possible interactions of
neutrophils with other cell types involved in I/R-injury in vivo
cannot be quantified. We chose this approach as it allows us
to investigate pathways and inflammatory responses specific
to neutrophils while avoiding expected or unanticipated cell–
cell signalling.
Our results provide insight into how volatile anaesthetics can
influence the accumulation of neutrophils in I/R-injury through
inhibition of neutrophil migration and b2-integrin expression.
Both sevoflurane and desflurane had comparable effects and
seem to interfere within the CXCR2 signalling pathway at a
site of action upstream of protein kinase C and downstream of
CXCR2. InhibitionofCXCR2 signalling might therefore contribute
to the well-established anti-inflammatory effect of volatile
anaesthetics for the development of I/R-injury in vivo.
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